Pharmaceuticals, Biotechnology and Life Sciences
Oasmia Pharmaceutical has named Anette Sjödin as Executive Vice President as of June 1, 2019 and Maria Nilsson Hagberg as Head of Regulatory Affairs as of April 18, 2019.
Oasmia Pharmaceutical has made a deal with Baxter BioPharma Solutions to manufacture Apealea in its site in Germany, so Oasmia can focus on other products in its own facilities.
After the Oasmia Pharmaceutical’s pivotal study OAS 07OVA conducted on ovarian cancer patients with disease relapse, showed that the risks…
Oasmia Pharmaceutical, a developer of a new generation of drugs within human and veterinary oncology, today presented positive results from…